Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Clinical trial NCT03562897 · COMPLETED

Trial details

NCT number: NCT03562897
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Ovarian Neoplasm Endocrine Gland Neoplasm Urogenital Neoplasms Ovarian Diseases Adnexal Diseases Genital Diseases, Female Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Endocrine System Diseases Gonadal Disorders Genital Neoplasm, Female

Start date: 2018-10-25
Primary completion: 2022-02-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.